Profile
ABOS VRTX ALNY REGN ARGX SGEN
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $74.51M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.06K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Daniel J. O'Connell Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABOS VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
ABOS VRTX ALNY REGN ARGX SGEN
Last Close $1.23 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $3.27 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.9 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -62.39 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 36.67 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
ABOS VRTX ALNY REGN ARGX SGEN
1 Month Return -13.38 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return 0.82 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return -4.28 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return -37.24 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return -28.49 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return -50.4 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1338.23 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ABOS VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -0.56 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -79.5 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -81.39 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -97.92 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 94.92 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -80888.76 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -394.1 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.09 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.1 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -1.94 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -1.95 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 236.69 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -66159.55 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -394.1 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.63 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -0.63 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -0.63 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
ABOS VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.1B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.71 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABOS VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.03B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.06B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.18B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.2B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.03B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.24B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABOS VRTX ALNY REGN ARGX SGEN
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.09B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.2
AARD Aardvark Therapeutics, Inc. Common Stock 10.99
ABCL AbCellera Biologics Inc. 4.565
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.046281
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.425
ABVC ABVC BioPharma, Inc. 2.8645
ABVX Abivax SA American Depositary Shares 81.05
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.965
ACIU AC Immune SA 2.46
ACLX Arcellx, Inc. 76.42
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 238.95
VTI Vanguard Total Stock Market Index Fund 0.00008 325.11
IBB iShares Biotechnology ETF 0.01258 141.02
IWN iShares Russell 2000 Value ETF 0.00035 175.2
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 57.405
VXF Vanguard Extended Market Index Fund 0.00053 209.23
HDG ProShares Hedge Replication ETF 0.000269689 51.245
UWM ProShares Ultra Russell2000 0.00157102 45.55
VTHR Vanguard Russell 3000 Index Fund 0 291.555
IWC iShares Micro-Cap ETF 0.01528 146.14
URTY ProShares UltraPro Russell2000 0.00125687 51.56
VTWV Vanguard Russell 2000 Value Index Fund 0.00373 155.19
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0.00168 96.94
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 45.6
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00018 110.68
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.67
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.47
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.46
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.45
BMED BlackRock Future Health ETF 0.03 26.49
DFAU Dimensional US Core Equity Market ETF 0.00048189 45.32
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 23.73
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 58.675
DFAS Dimensional U.S. Small Cap ETF 0.0001142 68.45
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 38.295
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 5.882
VTSAX Vanguard Total Stock Market Index Fund 0 158.41
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 6.9725
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00056 158.72
VITSX Vanguard Total Stock Market Index Fund 0 158.44
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 6.9335
IBRN iShares Neuroscience and Healthcare ETF 0.17376 25.5232
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 16
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00056 158.73
AVSC Avantis U.S. Small Cap Equity ETF 0 57.28
VTS.AX Vanguard US Total Market Shares Index ETF 0.00008 487.64
DCOR Dimensional ETF Trust 0.00005219 71.42
VEMPX Vanguard Extended Market Index InstlPlus 0.00056 391.7
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00008 297.22
RSSL Global X Funds 0 94.045
DXUV Dimensional ETF Trust 0.0000186 58.03
Unlock